Octreotide vs Semax
Overview
Octreotide is primarily a hormonal peptide, while Semax is used for cognitive enhancement.
This page compares Octreotide and Semax across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Octreotide | Semax | |
|---|---|---|
| Category | Hormonal | Cognitive Enhancement |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) | 300-600 mcg |
| Frequency | Every 4 weeks (LAR); two to four times daily (immediate-release) | daily |
| Reported benefits | Reduction of growth hormone and IGF-1 in acromegaly, suppression of carcinoid flushing and diarrhea, control of VIPoma-associated watery diarrhea, antiproliferative effect on low-grade neuroendocrine tumors, reduction of urinary 5-HIAA biomarkers | Enhanced focus and memory, neuroprotection, improved learning, mood enhancement, stress resilience |
| Reported side effects | Gallstones and biliary sludge, diarrhea, nausea, abdominal discomfort, sinus bradycardia, hyperglycemia, hypoglycemia, hypothyroidism, steatorrhea, injection-site pain | Generally safe. Possible: overstimulation, sleep disturbances if taken late |
Key differences
Primary use. Octreotide is categorised under Hormonal, while Semax falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Octreotide: FDA-approved. Semax: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Octreotide is typically dosed at 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) (Every 4 weeks (LAR); two to four times daily (immediate-release)). Semax is typically dosed at 300-600 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Octreotide and Semax has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Octreotide and Semax?
- Octreotide is primarily a hormonal peptide, while Semax is used for cognitive enhancement. Octreotide is FDA-approved for one or more indications, whereas Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Octreotide used for?
- FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988.
- What is Semax used for?
- Cognitive enhancement, focus, memory.
- Can you take Octreotide and Semax together?
- Some users combine peptides within a single protocol, but stacking Octreotide and Semax has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Octreotide or Semax FDA-approved?
- Octreotide is FDA-approved for one or more indications. Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Octreotide — full monograph: mechanism, research, dosing & references
- Semax — full monograph: mechanism, research, dosing & references